Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance

Lars Ketscher, Ronny Hannß, David J. Moralese, Anja Basters, Susana Guerra, Tobias Goldmann, Annika Hausmann, Marco Prinz, Ronald Naumann, Andrew Pekosz, Olaf Utermöhlen, Deborah J. Lenschow, Klaus Peter Knobeloch

Research output: Contribution to journalArticle

Abstract

Protein modification by the ubiquitin-like protein ISG15 is an interferon (IFN) effector system, which plays a major role in antiviral defense. ISG15 modification is counteracted by the isopeptidase USP18, a major negative regulator of IFN signaling, which was also shown to exert its regulatory function in an isopeptidase-independent manner. To dissect enzymatic and nonenzymatic functions of USP18 in vivo,we generated knock-inmice (USP18C61A/ C61A) expressing enzymatically inactive USP18. USP18C61A/C61A mice displayed increased levels of ISG15 conjugates, validating that USP18 is a major ISG15 isopeptidase in vivo. Unlike USP18-/- mice, USP18C61A/ C61A animals did not exhibit morphological abnormalities, fatal IFN hypersensitivity, or increased lethality, clearly showing that major USP18 functions are unrelated to its protease activity. Strikingly, elevated ISGylation in USP18 C61A/ C61Amice was accompanied by increased viral resistance against vaccinia virus and influenza B virus infections. Enhanced resistance upon influenza B infection in USP18C61A/ C61A mice was completely reversed in USP18C61A/ C61A mice, which additionally lack ISG15, providing evidence that the observed reduction in viral titers is ISG15 dependent. These results suggest that increasing ISGylation by specific inhibition of USP18 protease activity could constitute a promising antiviral strategy with only a minimal risk of severe adverse effects.

Original languageEnglish (US)
Pages (from-to)1577-1582
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume112
Issue number5
DOIs
StatePublished - Feb 3 2015

Fingerprint

Interferons
Antiviral Agents
Peptide Hydrolases
Ubiquitins
Influenza B virus
Vaccinia virus
Virus Diseases
Human Influenza
Hypersensitivity
isopeptidase
Infection
Proteins

Keywords

  • Interferonubiquitin
  • ISG15
  • Isopeptidaseinfluenza
  • UBP43

ASJC Scopus subject areas

  • General

Cite this

Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. / Ketscher, Lars; Hannß, Ronny; Moralese, David J.; Basters, Anja; Guerra, Susana; Goldmann, Tobias; Hausmann, Annika; Prinz, Marco; Naumann, Ronald; Pekosz, Andrew; Utermöhlen, Olaf; Lenschow, Deborah J.; Knobeloch, Klaus Peter.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 5, 03.02.2015, p. 1577-1582.

Research output: Contribution to journalArticle

Ketscher, L, Hannß, R, Moralese, DJ, Basters, A, Guerra, S, Goldmann, T, Hausmann, A, Prinz, M, Naumann, R, Pekosz, A, Utermöhlen, O, Lenschow, DJ & Knobeloch, KP 2015, 'Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance', Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 5, pp. 1577-1582. https://doi.org/10.1073/pnas.1412881112
Ketscher, Lars ; Hannß, Ronny ; Moralese, David J. ; Basters, Anja ; Guerra, Susana ; Goldmann, Tobias ; Hausmann, Annika ; Prinz, Marco ; Naumann, Ronald ; Pekosz, Andrew ; Utermöhlen, Olaf ; Lenschow, Deborah J. ; Knobeloch, Klaus Peter. / Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. In: Proceedings of the National Academy of Sciences of the United States of America. 2015 ; Vol. 112, No. 5. pp. 1577-1582.
@article{48f9a215c78241ed900b43ae4b6b2977,
title = "Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance",
abstract = "Protein modification by the ubiquitin-like protein ISG15 is an interferon (IFN) effector system, which plays a major role in antiviral defense. ISG15 modification is counteracted by the isopeptidase USP18, a major negative regulator of IFN signaling, which was also shown to exert its regulatory function in an isopeptidase-independent manner. To dissect enzymatic and nonenzymatic functions of USP18 in vivo,we generated knock-inmice (USP18C61A/ C61A) expressing enzymatically inactive USP18. USP18C61A/C61A mice displayed increased levels of ISG15 conjugates, validating that USP18 is a major ISG15 isopeptidase in vivo. Unlike USP18-/- mice, USP18C61A/ C61A animals did not exhibit morphological abnormalities, fatal IFN hypersensitivity, or increased lethality, clearly showing that major USP18 functions are unrelated to its protease activity. Strikingly, elevated ISGylation in USP18 C61A/ C61Amice was accompanied by increased viral resistance against vaccinia virus and influenza B virus infections. Enhanced resistance upon influenza B infection in USP18C61A/ C61A mice was completely reversed in USP18C61A/ C61A mice, which additionally lack ISG15, providing evidence that the observed reduction in viral titers is ISG15 dependent. These results suggest that increasing ISGylation by specific inhibition of USP18 protease activity could constitute a promising antiviral strategy with only a minimal risk of severe adverse effects.",
keywords = "Interferonubiquitin, ISG15, Isopeptidaseinfluenza, UBP43",
author = "Lars Ketscher and Ronny Hann{\ss} and Moralese, {David J.} and Anja Basters and Susana Guerra and Tobias Goldmann and Annika Hausmann and Marco Prinz and Ronald Naumann and Andrew Pekosz and Olaf Uterm{\"o}hlen and Lenschow, {Deborah J.} and Knobeloch, {Klaus Peter}",
year = "2015",
month = "2",
day = "3",
doi = "10.1073/pnas.1412881112",
language = "English (US)",
volume = "112",
pages = "1577--1582",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "5",

}

TY - JOUR

T1 - Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance

AU - Ketscher, Lars

AU - Hannß, Ronny

AU - Moralese, David J.

AU - Basters, Anja

AU - Guerra, Susana

AU - Goldmann, Tobias

AU - Hausmann, Annika

AU - Prinz, Marco

AU - Naumann, Ronald

AU - Pekosz, Andrew

AU - Utermöhlen, Olaf

AU - Lenschow, Deborah J.

AU - Knobeloch, Klaus Peter

PY - 2015/2/3

Y1 - 2015/2/3

N2 - Protein modification by the ubiquitin-like protein ISG15 is an interferon (IFN) effector system, which plays a major role in antiviral defense. ISG15 modification is counteracted by the isopeptidase USP18, a major negative regulator of IFN signaling, which was also shown to exert its regulatory function in an isopeptidase-independent manner. To dissect enzymatic and nonenzymatic functions of USP18 in vivo,we generated knock-inmice (USP18C61A/ C61A) expressing enzymatically inactive USP18. USP18C61A/C61A mice displayed increased levels of ISG15 conjugates, validating that USP18 is a major ISG15 isopeptidase in vivo. Unlike USP18-/- mice, USP18C61A/ C61A animals did not exhibit morphological abnormalities, fatal IFN hypersensitivity, or increased lethality, clearly showing that major USP18 functions are unrelated to its protease activity. Strikingly, elevated ISGylation in USP18 C61A/ C61Amice was accompanied by increased viral resistance against vaccinia virus and influenza B virus infections. Enhanced resistance upon influenza B infection in USP18C61A/ C61A mice was completely reversed in USP18C61A/ C61A mice, which additionally lack ISG15, providing evidence that the observed reduction in viral titers is ISG15 dependent. These results suggest that increasing ISGylation by specific inhibition of USP18 protease activity could constitute a promising antiviral strategy with only a minimal risk of severe adverse effects.

AB - Protein modification by the ubiquitin-like protein ISG15 is an interferon (IFN) effector system, which plays a major role in antiviral defense. ISG15 modification is counteracted by the isopeptidase USP18, a major negative regulator of IFN signaling, which was also shown to exert its regulatory function in an isopeptidase-independent manner. To dissect enzymatic and nonenzymatic functions of USP18 in vivo,we generated knock-inmice (USP18C61A/ C61A) expressing enzymatically inactive USP18. USP18C61A/C61A mice displayed increased levels of ISG15 conjugates, validating that USP18 is a major ISG15 isopeptidase in vivo. Unlike USP18-/- mice, USP18C61A/ C61A animals did not exhibit morphological abnormalities, fatal IFN hypersensitivity, or increased lethality, clearly showing that major USP18 functions are unrelated to its protease activity. Strikingly, elevated ISGylation in USP18 C61A/ C61Amice was accompanied by increased viral resistance against vaccinia virus and influenza B virus infections. Enhanced resistance upon influenza B infection in USP18C61A/ C61A mice was completely reversed in USP18C61A/ C61A mice, which additionally lack ISG15, providing evidence that the observed reduction in viral titers is ISG15 dependent. These results suggest that increasing ISGylation by specific inhibition of USP18 protease activity could constitute a promising antiviral strategy with only a minimal risk of severe adverse effects.

KW - Interferonubiquitin

KW - ISG15

KW - Isopeptidaseinfluenza

KW - UBP43

UR - http://www.scopus.com/inward/record.url?scp=84922326351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922326351&partnerID=8YFLogxK

U2 - 10.1073/pnas.1412881112

DO - 10.1073/pnas.1412881112

M3 - Article

VL - 112

SP - 1577

EP - 1582

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 5

ER -